Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 8:07 PM View:  | Redfield Robert Acting Chief Medical Officer | Traws Pharma, Inc. (TRAW) | 01-Apr-24 | Grant | 97,500 | -- | -- | 100% 0 to 97.5K | |
| 03-Apr-24 8:03 PM View: | Cautreels Werner Chief Executive Officer Director | Traws Pharma, Inc. (TRAW) | 01-Apr-24 | Grant | 200,000 | -- | -- | 100% 0 to 200.0K | |
| 03-Apr-24 7:59 PM View: | Dukes Iain D. Executive Chairman Director | Traws Pharma, Inc. (TRAW) | 01-Apr-24 | Grant | 1,645,100 | -- | -- | 1226% 134.19K to 1.78M | |
| 03-Apr-24 8:04 PM View: | Pauza Charles David Chief Science Officer Virology | Traws Pharma, Inc. (TRAW) | 01-Apr-24 | Grant | 97,500 | -- | -- | 100% 0 to 97.5K | |
| 03-Apr-24 8:01 PM View: | Savchuk Nikolay Chief Operating Officer Director | Traws Pharma, Inc. (TRAW) | 01-Apr-24 | Grant | 2,530,630 | -- | -- | 1886% 134.19K to 2.66M | |
| 15-Mar-24 5:36 PM View: | Fruchtman Steven M President, Chief Executive Off Director | Traws Pharma, Inc. (TRAW) | 14-Mar-24 | Payment of Exercise | 8,727 | $0.90 | $7,854.30 | (10%) 83.52K to 74.79K | |
| 15-Mar-24 5:40 PM View: | Guerin Mark Patrick CFO AND COO | Traws Pharma, Inc. (TRAW) | 14-Mar-24 | Payment of Exercise | 2,591 | $0.90 | $2,331.90 | (7%) 38.57K to 35.98K | |
| 15-Mar-24 5:40 PM View: | Guerin Mark Patrick CFO AND COO | Traws Pharma, Inc. (TRAW) | 13-Mar-24 | Option Exercise | 8,666 | -- | -- | 29% 29.9K to 38.57K | |
| 15-Mar-24 5:36 PM View: | Fruchtman Steven M President, Chief Executive Off Director | Traws Pharma, Inc. (TRAW) | 13-Mar-24 | Option Exercise | 23,111 | -- | -- | 38% 60.41K to 83.52K | |
| 09-Feb-24 5:38 PM View: | Guerin Mark Patrick CFO AND COO | Traws Pharma, Inc. (TRAW) | 07-Feb-24 | Payment of Exercise | 2,443 | $0.67 | $1,636.81 | (8%) 32.34K to 29.9K | |
| 09-Feb-24 5:36 PM View: | Fruchtman Steven M President, Chief Executive Off Director | Traws Pharma, Inc. (TRAW) | 07-Feb-24 | Option Exercise | 21,320 | -- | -- | 44% 48.3K to 69.62K | |
| 09-Feb-24 5:36 PM View: | Fruchtman Steven M President, Chief Executive Off Director | Traws Pharma, Inc. (TRAW) | 07-Feb-24 | Payment of Exercise | 9,212 | $0.67 | $6,172.04 | (13%) 69.62K to 60.41K | |
| 09-Feb-24 5:38 PM View: | Guerin Mark Patrick CFO AND COO | Traws Pharma, Inc. (TRAW) | 07-Feb-24 | Option Exercise | 6,900 | -- | -- | 27% 25.44K to 32.34K | |
| 04-Aug-23 4:45 PM View: | Guerin Mark Patrick CFO AND COO | Traws Pharma, Inc. (TRAW) | 03-Aug-23 | Payment of Exercise | 1,422 | $1.02 | $1,450.44 | (5%) 26.87K to 25.44K | |
| 04-Aug-23 4:42 PM View: | Fruchtman Steven M President, Chief Executive Off Director | Traws Pharma, Inc. (TRAW) | 03-Aug-23 | Payment of Exercise | 4,744 | $1.01 | $4,791.44 | (9%) 53.04K to 48.3K | |
| 04-Aug-23 4:42 PM View: | Fruchtman Steven M President, Chief Executive Off Director | Traws Pharma, Inc. (TRAW) | 02-Aug-23 | Option Exercise | 12,567 | -- | -- | 31% 40.48K to 53.04K | |
| 04-Aug-23 4:45 PM View: | Guerin Mark Patrick CFO AND COO | Traws Pharma, Inc. (TRAW) | 02-Aug-23 | Option Exercise | 4,750 | -- | -- | 21% 22.12K to 26.87K | |
| 13-Jun-23 4:54 PM View: | Guerin Mark Patrick CFO AND COO | Traws Pharma, Inc. (TRAW) | 12-Jun-23 | Option Exercise | 5,500 | -- | -- | 30% 18.19K to 23.69K | |
| 13-Jun-23 4:54 PM View: | Guerin Mark Patrick CFO AND COO | Traws Pharma, Inc. (TRAW) | 12-Jun-23 | Payment of Exercise | 1,575 | $1.14 | $1,790.77 | (7%) 23.69K to 22.12K | |
| 08-Feb-23 5:58 PM View: | Gelder Mark S. Md Chief Medical Officer | Traws Pharma, Inc. (TRAW) | 07-Feb-23 | Option Exercise | 5,833 | -- | -- | 99% 5.9K to 11.73K | |
| 08-Feb-23 6:00 PM View: | Fruchtman Steven M President, Chief Executive Off Director | Traws Pharma, Inc. (TRAW) | 07-Feb-23 | Payment of Exercise | 6,977 | $1.36 | $9,488.72 | (15%) 47.45K to 40.48K | |
| 08-Feb-23 5:58 PM View: | Gelder Mark S. Md Chief Medical Officer | Traws Pharma, Inc. (TRAW) | 07-Feb-23 | Payment of Exercise | 1,242 | $1.36 | $1,689.12 | (11%) 11.73K to 10.49K | |
| 08-Feb-23 5:56 PM View: | Guerin Mark Patrick CFO AND COO | Traws Pharma, Inc. (TRAW) | 07-Feb-23 | Option Exercise | 6,900 | -- | -- | 53% 13.08K to 19.98K | |
| 08-Feb-23 5:56 PM View: | Guerin Mark Patrick CFO AND COO | Traws Pharma, Inc. (TRAW) | 07-Feb-23 | Payment of Exercise | 1,785 | $1.36 | $2,427.60 | (9%) 19.98K to 18.19K | |
| 08-Feb-23 6:00 PM View: | Fruchtman Steven M President, Chief Executive Off Director | Traws Pharma, Inc. (TRAW) | 07-Feb-23 | Option Exercise | 21,320 | -- | -- | 82% 26.13K to 47.45K | |
| 04-Aug-22 4:34 PM View: | Gelder Mark S. Md Chief Medical Officer | Traws Pharma, Inc. (TRAW) | 03-Aug-22 | Payment of Exercise | 1,135 | $1.32 | $1,498.20 | (16%) 7.03K to 5.9K | |
| 04-Aug-22 4:38 PM View: | Guerin Mark Patrick CFO AND COO | Traws Pharma, Inc. (TRAW) | 03-Aug-22 | Payment of Exercise | 1,355 | $1.32 | $1,788.60 | (9%) 14.43K to 13.08K | |
| 04-Aug-22 4:30 PM View: | Fruchtman Steven M President, Chief Executive Off Director | Traws Pharma, Inc. (TRAW) | 03-Aug-22 | Payment of Exercise | 4,562 | $1.32 | $6,021.84 | (15%) 30.7K to 26.13K | |
| 04-Aug-22 4:38 PM View: | Guerin Mark Patrick CFO AND COO | Traws Pharma, Inc. (TRAW) | 02-Aug-22 | Option Exercise | 4,750 | -- | -- | 49% 9.68K to 14.43K | |
| 04-Aug-22 4:30 PM View: | Fruchtman Steven M President, Chief Executive Off Director | Traws Pharma, Inc. (TRAW) | 02-Aug-22 | Option Exercise | 12,566 | -- | -- | 69% 18.13K to 30.7K | |
| 04-Aug-22 4:34 PM View: | Gelder Mark S. Md Chief Medical Officer | Traws Pharma, Inc. (TRAW) | 02-Aug-22 | Option Exercise | 4,650 | -- | -- | 195% 2.38K to 7.03K | |
| 31-Jan-22 8:41 AM View: | Oler Abraham N. SVP Corp Dev & Gen Counsel | Traws Pharma, Inc. (TRAW) | 28-Jan-22 | Private Purchase (Planned) | 1,500 | $1.67 | $2,505.00 | 7% 23.01K to 24.51K | |
| 24-Jan-22 8:40 AM View: | Oler Abraham N. SVP Corp Dev & Gen Counsel | Traws Pharma, Inc. (TRAW) | 21-Jan-22 | Private Purchase (Planned) | 1,500 | $2.02 | $3,030.00 | 7% 21.51K to 23.01K | |
| 18-Jan-22 9:12 AM View: | Oler Abraham N. SVP Corp Dev & Gen Counsel | Traws Pharma, Inc. (TRAW) | 14-Jan-22 | Market Purchase (Planned) | 1,500 | $2.20 | $3,300.00 | 7% 20.01K to 21.51K | 5% |
| 10-Jan-22 8:39 AM View: | Oler Abraham N. SVP Corp Dev & Gen Counsel | Traws Pharma, Inc. (TRAW) | 07-Jan-22 | Market Purchase (Planned) | 1,500 | $2.39 | $3,585.00 | 8% 18.51K to 20.01K | (4%) |
| 23-Nov-21 9:20 AM View: | Oler Abraham N. SVP Corp Dev & Gen Counsel | Traws Pharma, Inc. (TRAW) | 19-Nov-21 | Market Purchase | 1,000 | $3.16 | $3,160.00 | 6% 17.51K to 18.51K | (8%) |
| 19-Nov-21 8:45 AM View: | Oler Abraham N. SVP Corp Dev & Gen Counsel | Traws Pharma, Inc. (TRAW) | 18-Nov-21 | Exercise (in-the money or at-the-money) | 5,000 | $3.00 | $15,000.00 | 40% 12.51K to 17.51K | 5% |
| 28-Sep-21 12:34 PM View: | Fruchtman Steven M President, Chief Executive Off Director | Traws Pharma, Inc. (TRAW) | 28-Sep-21 | Market Purchase | 2,381 | $4.20 | $10,000.20 | 15% 15.75K to 18.13K | (7%) |
| 29-Sep-21 8:27 AM View: | Oler Abraham N. SVP Corp Dev & Gen Counsel | Traws Pharma, Inc. (TRAW) | 28-Sep-21 | Market Purchase | 2,381 | $4.20 | $10,000.20 | 23% 10.13K to 12.52K | (9%) |
| 28-Sep-21 12:32 PM View: | Marino James J Director | Traws Pharma, Inc. (TRAW) | 28-Sep-21 | Market Purchase | 5,952 | $4.20 | $24,998.40 | 39% 15.38K to 21.33K | (5%) |
| 29-Sep-21 8:25 AM View: | Gelder Mark S. Md Chief Medical Officer | Traws Pharma, Inc. (TRAW) | 28-Sep-21 | Market Purchase | 2,381 | $4.20 | $10,000.20 | 100% 0 to 2.38K | (9%) |
| 17-Feb-21 8:48 AM View: | Fruchtman Steven M President, Chief Executive Off Director | Traws Pharma, Inc. (TRAW) | 16-Feb-21 | Private Purchase | 20,000 | $1.00 | $20,000.00 | 9% 216.23K to 236.23K | |
| 17-Feb-21 8:57 AM View: | Oler Abraham N. SVP Corp Dev & Gen Counsel | Traws Pharma, Inc. (TRAW) | 16-Feb-21 | Private Purchase | 12,000 | $1.00 | $12,000.00 | 9% 140.0K to 152.0K | |
| 17-Feb-21 8:46 AM View: | Marino James J Director | Traws Pharma, Inc. (TRAW) | 16-Feb-21 | Private Purchase | 25,000 | $1.00 | $25,000.00 | 12% 205.72K to 230.72K | |
| 17-Feb-21 8:45 AM View: | Shoemaker Mary Teresa Director | Traws Pharma, Inc. (TRAW) | 16-Feb-21 | Private Purchase | 13,000 | $1.00 | $13,000.00 | 34% 37.73K to 50.73K | |
| 17-Feb-21 8:55 AM View: | Guerin Mark Patrick Chief Financial Officer | Traws Pharma, Inc. (TRAW) | 16-Feb-21 | Private Purchase | 15,000 | $1.00 | $15,000.00 | 12% 130.21K to 145.21K | |
| 14-Dec-20 9:00 AM View: | Oler Abraham N. SVP Corp Dev & Gen Counsel | Traws Pharma, Inc. (TRAW) | 11-Dec-20 | Market Purchase | 30,000 | $0.32 | $9,600.00 | 27% 110.0K to 140.0K | 49% |
| 30-Nov-20 5:11 PM View: | Guerin Mark Patrick Chief Financial Officer | Traws Pharma, Inc. (TRAW) | 27-Nov-20 | Market Purchase | 4,614 | $0.26 | $1,199.64 | 4% 125.6K to 130.21K | 65% |
| 30-Nov-20 5:11 PM View: | Guerin Mark Patrick Chief Financial Officer | Traws Pharma, Inc. (TRAW) | 25-Nov-20 | Market Purchase | 16,755 | $0.26 | $4,356.30 | 15% 108.84K to 125.6K | 71% |
| 30-Nov-20 5:14 PM View: | Shoemaker Mary Teresa Director | Traws Pharma, Inc. (TRAW) | 25-Nov-20 | Market Purchase | 37,735 | $0.26 | $9,999.77 | 100% 0 to 37.73K | 68% |
